We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01861002
Recruitment Status : Completed
First Posted : May 23, 2013
Last Update Posted : June 2, 2016
Gateway for Cancer Research
University of Southern California
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2014
  Study Completion Date : July 2014